An open-label, two-cohort study to assess the effect of lamotrigine and phenytoin on the pharmacokinetics of atorvastatin in healthy subjects.

Trial Profile

An open-label, two-cohort study to assess the effect of lamotrigine and phenytoin on the pharmacokinetics of atorvastatin in healthy subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Aug 2017

At a glance

  • Drugs Atorvastatin; Lamotrigine; Phenytoin
  • Indications Alzheimer's disease; Bipolar disorders; Cardiovascular disorders; Diabetic nephropathies; Epilepsy; Hypercholesterolaemia; Hyperlipoproteinaemia type II; Hyperlipoproteinaemia type III; Hypertriglyceridaemia; Lennox-Gastaut syndrome; Low HDL cholesterol; Partial epilepsies; Tonic-clonic epilepsy
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 14 Oct 2010 Actual end date (September 2008) added as reported by ClinicalTrials.gov.
    • 14 Oct 2008 Status changed from active, no longer recruiting to completed as reported by Clinicaltrials.gov.
    • 20 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top